Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Neutropenia (Fever neutropenic).php on line 2
Neutropenia (Fever neutropenic)
LE WE PMID CA
Neutropenia (Fever neutropenic)4535Neutropenie (Fieber)

Neutropenia (Fever neutropenic)

Sepsis

2009  
1
Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia.
[19346292] J Antimicrob Chemother 63(6): 1276-85 (2009)
2009  
2
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and comments.
[19372182] J Antimicrob Chemother 63 Suppl 1(-): i41-3 (2009)
2009  
3
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Mucositis: from febrile neutropenia to febrile mucositis.
[19372181] J Antimicrob Chemother 63 Suppl 1(-): i36-40 (2009)
2009  
4
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Moulds: diagnosis and treatment.
[19372180] J Antimicrob Chemother 63 Suppl 1(-): i31-5 (2009)
2009  
5
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years.
[19372179] J Antimicrob Chemother 63 Suppl 1(-): i3-13 (2009)
2009  
6
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections.
[19372178] J Antimicrob Chemother 63 Suppl 1(-): i27-30 (2009)
2009  
7
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Management of mycoses in neutropenic patients: a brief history, 1960-2008.
[19372177] J Antimicrob Chemother 63 Suppl 1(-): i23-6 (2009)
2006  
8
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
[16459344] J Antimicrob Chemother 57(4): 628-38 (2006)
2005  
9
Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
[16120631] J Antimicrob Chemother 56 Suppl 1(-): i23-i32 (2005)
2005  
10
Defining invasive fungal infections in neutropenic or stem cell transplant patients.
[16120629] J Antimicrob Chemother 56 Suppl 1(-): i12-i16 (2005)
2004  
11
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.
[15201227] J Antimicrob Chemother 54(1): 29-37 (2004)
1998  
12
Fungal infections in neutropenia: current problems and chemotherapeutic control.
[9688455] J Antimicrob Chemother 41 Suppl D(-): 95-105 (1998)
1998  
13
Viral infections in neutropenia--current problems and chemotherapeutic control.
[9688454] J Antimicrob Chemother 41 Suppl D(-): 81-93 (1998)
1998  
14
The evolution of the empirical management of fever and neutropenia in cancer patients.
[9688453] J Antimicrob Chemother 41 Suppl D(-): 65-80 (1998)
1998  
15
The diagnostic and therapeutic approach to lower respiratory tract infections in the neutropenic patient.
[9688451] J Antimicrob Chemother 41 Suppl D(-): 51-5 (1998)
1998  
16
Science and pragmatism in the treatment and prevention of neutropenic infection.
[9688448] J Antimicrob Chemother 41 Suppl D(-): 13-24 (1998)
1998  
17
The changing pattern of infection in neutropenic patients.
[9688447] J Antimicrob Chemother 41 Suppl D(-): 7-11 (1998)
1997  
18
Antifungal prophylaxis during neutropenia and immunodeficiency.
[9227863] Clin Microbiol Rev 10(3): 477-504 (1997)
2006  
19
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
[16977651] Cancer 107(8): 1743-51 (2006)
2005  
20
Bacterial infections in low-risk, febrile neutropenic patients.
[15937905] Cancer 104(2): 422-6 (2005)
2005  
21
Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.
[15666328] Cancer 103(6): 1103-13 (2005)
2004  
22
Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.
[14716755] Cancer 100(2): 228-37 (2004)
2000  
23
Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
[11013378] Cancer 89(7): 1611-25 (2000)
2001  
24
1997  
25
The evolution of antibiotic therapy for neutropenic patients.
[10068270] Clin Cancer Res 3(12 Pt 2): 2660-5 (1997)
2010  
26
Management of febrile neutropenia: ESMO Clinical Practice Guidelines.
[20555092] Ann Oncol 21 Suppl 5(-): v252-6 (2010)
2009  
27
Management of febrile neutropenia: ESMO clinical recommendations.
[19454445] Ann Oncol 20 Suppl 4(-): 166-9 (2009)
2003  
28
Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis.
[12763980] BMJ 326(7399): 1111 (2003)
2002  
29
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.
[11850858] Clin Infect Dis 34(6): 730-51 (2002)
2007  
30
New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients.
[17530138] J Pediatr (Rio J) 83(2 Suppl): S54-63 (2007)
2005  
31
Febrile neutropenia in haematological malignancies.
[16519255] J Postgrad Med 51 Suppl 1(-): S42-8 (2005)
2008  
32
Canadian supportive care recommendations for the management of neutropenia in patients with cancer.
[18317581] Curr Oncol 15(1): 9-23 (2008)
2010  
33
Use of antimicrobial agents and granulocyte colony stimulating factors for febrile neutropenia in cancer patients in a tertiary care hospital in India.
[21131758] Indian J Cancer 47(4): 430-6 (2010)
2011  
34
The strategy of antibiotic use in critically ill neutropenic patients.
[21906359] Ann Intensive Care 1(1): 22 (2011)
2009  
35
Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study.
[19055662] Br J Haematol 144(5): 677-85 (2009)
2011  
36
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis.
[21943360] BMC Cancer 11(-): 404 (2011)
2011  
37
Antibacterial prophylaxis in neutropenic children with cancer.
[21647276] Pediatr Rep 3(1): e3 (2011)
2011  
38
Current evidence of antifungal prophylaxis and therapy in pediatric patients.
[21647279] Pediatr Rep 3(1): e6 (2011)
2011  
39
Empirical antifungal treatment: a valid alternative for invasive fungal infection.
[21947092] Rev Esp Quimioter 24(3): 117-22 (2011)
2010  
40
A systematic review of oral fungal infections in patients receiving cancer therapy.
[20449755] Support Care Cancer 18(8): 985-92 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Neutropenia (Fever neutropenic).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Neutropenia (Fever neutropenic).php on line 92